Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer
WELCOME to
    GBC e - journal
      Editor-in-Chief, D. Roukos, MD
WEB
LAST UPDATE : March 28, 08
    GBCNC Web Site
      Associate Editor: D. Trichopoulos, MD, Harvard/ U.S
FOCUS

Jan. 2008

Gbc in Scopus, Embase

SUBMIT YOUR PAPER
GBC
E JOURNAL
SERVICES
ARCHIVE
DOIs
REGISTER
    LOG IN
    NEW USER
INDIVIDUALS
INSTITUTIONS/ LIBRARIES
SUBMIT A MANUSCRIPT
Call for papers
Instruction
Copyright
Conflict
REVIEWERS
Contact Us
Links

GBC
  
CURRENT ISSUE

PERSPECTIVE
Tailoring surgery for breast cancer – Genetic Testing-based current practice and promises with Genomewide Association studies
Personalized medicine is a major goal. Novel genetic and genomic tools are needed to guide prevention and treatment of current common complex diseases including heart and cancer. more...
EDITORIAL

Bevacizumab for metastatic breast cancer – Promise and Concerns Antiangiogenic therapy for cancer represents a major hope of current research. Given the dependence of tumor growth and metastasis on blood vessels, agents that block the development on new blood vessels (neo-angiogenesis) might be effective in improving outcome of cancer patients. more...

 
SPECIAL ARTICLE
Prognostic Value of Epidermal Growth Factor Receptor in Breast Cancer: An Indian Experience
Τ he prognostic impact of EGFR positivity in Indian scenario and its correlation with known prognostic markers such as Estrogen receptor (ER) and HER-2 / neu oncogene more...

PERSONAL VIEW
Structural genomic variation: Human Copy Number Variation Promise Towards Personalized Medicine
Personalized medicine is a major research goal for this century. more...
COMMENTARIES
Da Vinci System for Robotic Rectal Cancer Surgery

VEGF and EGFR Antagonists for Gastric Cancer

 
MINIREVIEW

Treatment of Localized Gastric Adenocarcinoma
GBC
PAST ISSUE
BREAKTHROUGH OF THE YEAR 2007

> Basic science: HUMAN GENETIC VARIATION Genomewide techniques assessing single-nucleotide-polymorphisms (SNPs) and structural genetic variants (copy number, insertion, deletion) can reveal a healthy person's risk of developing common diseases as heart, diabetes or cancer (breast, lung, prostate, colorectal)
> Clinical oncological practice : Reduction in hormone prescription (HRT) decreases incidence of breast cancer; targeted agents for renal, liver cancer, adjuvant chemotherapy standard of care for gastric cancer. … more

PERSPECTIVE
Genetic testing guides decisions for preventing contralateral breast cancer
COMMENTARIES
Endoscopic Mucosal Resection - Is safe and Effective for Early ...
Benefits and harms in avoiding Axilla Lymphadenectomy in ...

REVIEW

Targeting HER2 Breast Cancer With Trastuzumab, Lapatinib and Other Novel Agents: Clinical Success and Resistance
ΚΛΗΡΟΝΟΜΙΚΟΣ ΚΑΡΚΙΝΟΣ ΜΑΣΤΟΥ - ΩΟΘΗΚΗΣ

Ο ΑΛΓΟΡΙΘΜΟΣ ΤΟΥ ΠΑΝΕΠΙΣΤΗΜΙΟΥ ΙΩΑΝΝΙΝΩΝ

Ολοκληρωμένο, 4-βημάτων μοντέλο για εξατομικευμένη κλινική απόφαση :

    •  BRCA θετικό τεστ
    •  BRCA αρνητικό τεστ         
Πληροφορίες

Web
Focus
TRANSLATIONAL RESEARCH:
 
Impact factor 2006 :5.364
 

1. Individualized preventive and therapeutic management of hereditary breast ovarian cancer .
Roukos Dh et al. Nat CPO 2007 (Oct ,)

HUMAN GENOME – VARIATION
PERSONAL GENOME –
PERSONALIZED MEDICINE
CANCER
  Breast
  Prostate
  Lung
BENIGN
  Heart
  Diabetes
HapMap II
ENCODE
TARGETING
Aromatase Inhibitor
---------------------------------

Online ISSN : 1109 - 7647
.   Print ISSN : 1109 - 7655 ..

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here. .
..please, read our policy about privacy and confidentiality of information and transparency of sponsorship. . ..
,http://www.dorotipo.gr www.hoteldimitra.grhttp://www.hoteldimitra.gr/

last update: March 28, 08